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Abstract
Surfactant-mediated removal of proteins from biomembranes invariably results in partial or
complete loss of function and disassembly of multi-protein complexes. We determined the
capacity of styrene-co-maleic acid (SMA) co-polymer to remove components of the cell division
machinery from the membrane of drug-resistant staphylococcal cells. SMA-lipid nanoparticles
solubilized FtsZ-PBP2-PBP2a complexes from intact cells, demonstrating the close physical
proximity of these proteins within the lipid bilayer. Exposure of bacteria to (-)-epicatechin
gallate, a polyphenolic agent that abolishes β-lactam resistance in staphylococci, disrupted the
association between PBP2 and PBP2a. Thus, SMA puriﬁcation provides a means to remove
native integral membrane protein assemblages with minimal physical disruption and shows
promise as a tool for the interrogation of molecular aspects of bacterial membrane protein
structure and function.
S Online supplementary data available from stacks.iop.org/NANO/25/285101/mmedia
Keywords: Staphylococcus aureus, poly(styrene-co-maleic acid), lipid nanoparticles, antibiotic
resistance, immunoafﬁnity chromatography
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1. Introduction
Integral membrane proteins participate in a variety of activ-
ities essential for survival, homeostasis and division. Many
function only within dynamic multi-protein assemblages
embedded in specialized lipid microdomains of the bacterial
cytoplasmic membrane (CM). Thus, the bacterial cell division
machinery is localized at mid-cell within a divisome of more
than 20 proteins [1]; their dynamic and amphipathic nature
makes them difﬁcult to study in their native state, as their
removal by surfactants leads to decreased structural integrity,
complex disassembly and loss of activity. Advances in
membrane solubilization have enabled surfactant-free
extraction and puriﬁcation of functionally active membrane
proteins [2, 3]. Amphipathic poly(styrene-co-maleic acid)
(SMA), soluble at neutral and alkaline pH and insoluble at
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lower pH, auto-assembles at neutral or alkaline pH into
membranes to form discoidal nanostructures around mem-
brane proteins and associated lipids. Preservation of the native
lipid environment of embedded proteins yields correctly fol-
ded, functionally active protein. The technique has been used
to remove and purify functionally active proteins from lipo-
somes [2–4] and over-expressed proteins from isolated
membranes of eukaryotes and prokaryotes. SMA-lipid parti-
cles (SMALPs) have also been employed to remove respira-
tory enzyme complexes from mitochondrial membranes [5],
suggesting that SMALP encapsulation provides a tool to
identify and characterize protein complexes in which mono-
meric components are in close physical proximity.
Staphylococcus aureus rapidly acquires genes encoding
antibiotic resistance; strains resistant to β-lactam agents,
typiﬁed by methicillin-resistant S. aureus (MRSA), are
usually insensitive to other antibiotic classes and there are few
treatment options [6]. MRSA is resistant to β-lactam drugs
due to acquisition of the mecA gene encoding penicillin-
binding protein (PBP) 2a, an enzyme that takes over the
transpeptidase function of PBP2 following β-lactam inacti-
vation of the PBP2 transpeptidase, to ensure continued
synthesis of cell wall peptidoglycan [7]. PBPs are embedded
in the CM, which is comprised of an asymmetric array of
lipids with differing charge characteristics, in the main
phosphatidylglycerol (PG), lysyl-PG and cardiolipin [8]. It
has proven difﬁcult to determine the spatial proximity of
PBP2 and PBP2a in the CM, even though they form part of
the cell division machinery at the division septum; divisome
assembly is regulated by polymerization of the tubulin
homologue FtsZ to a ring-like structure that acts as a scaffold
for recruitment of other proteins, including PBPs [1, 9].
Membrane-intercalating agents that abrogate β-lactam resis-
tance disperse PBP2 from the septum [8] and conversion to
drug susceptibility may be due to disruption of functional and
spatial associations between these proteins. We used the
SMALP technique to determine that PBP2/PBP2a complexes
can be captured together in nanoparticles from normally
dividing MRSA cells and to demonstrate that the drug
resistance modiﬁer (-)-epicatechin gallate (ECg) alters the
spatial relationship between the two proteins.
2. Experimental details
Epidemic MRSA isolate EMRSA-16 was from a clinical
sample obtained at the Royal Free Hospital (London, UK).
Methicillin-susceptible S. aureus SH1000 was obtained from
Alex O’Neill (University of Leeds, UK). Bacteria were grown
in Mueller-Hinton broth (Oxoid) to mid-logarithmic phase at
35 °C with constant agitation and aeration; PBP2a was
induced with sub-inhibitory concentrations (125 μg l−1) of
oxacillin. Lysostaphin, a glycine–glycine endopeptidase, and
the protease and phosphatase inhibitor mixture HALT were
purchased from Sigma-Aldrich. Anti-PBP2 antiserum was
produced in rabbits with recombinant his6-tagged PBP2;
mouse anti-PBP2a antibody was purchased from My Bio-
source and 1,2-dimyristoyl-sn-glycero-3-phosphocholine
(DMPC) from Avanti Polar Lipids. Rabbit anti-FtsZ anti-
serum was a gift from Jeff Errington (Newcastle University,
UK). SMA was composed of styrene and maleic acid residues
in a ratio of 2:1 and was synthesized in-house; 5% stock
solutions of SMA were prepared in 1.0M NaCl and reﬂuxed
for 2 h followed by overnight dialysis at 4 °C in 50 mM Tris-
HCl (pH 8.0). The composition of the lyophilized product
was conﬁrmed by FTIR. ECg was a gift from Mitsui Norin,
Tokyo, Japan and was used at a concentration of 12.5 mg l−1.
Proteins were separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) on a 10%
acrylamide/ bis-acrylamide gel matrix and visualized with
Coomassie brilliant blue (Sigma-Aldrich) with a limit of
detection of 0.2 μg. N-(2-hydroxy-1,1-bis(hydroxymethyl)
ethyl) glycine (tricine) modiﬁcation of SDS-PAGE was also
used to avoid aggregation of membrane proteins in the gel,
essentially as described by Schägger [10]. Protein-containing
samples were concentrated in Vivaspin columns (<10
000 kDa) to approximately 20 mgml−1 protein. For Western
blotting, proteins were transferred by electrophoresis to Mil-
lipore polyvinylidene membranes and probed with antibodies
to proteins of interest. Binding was detected with monoclonal
secondary antibody conjugated to horseradish peroxidase
(HRP) followed by peroxide substrate and Supersignal West
Pico Chemiluminescent Substrate (Thermo Scientiﬁc), an
enhanced chemiluminescence HRP substrate. Different sec-
ondary antibodies were used for detection of PBP2 (anti-
rabbit) and PBP2a (anti-mouse). For transmission electron
microscopy (TEM), suspensions were dropped on a grid,
washed twice with 50 mM Tris buffer, stained with uranyl
acetate [2] and viewed and photographed using a Philips 201
microscope.
Protein content of nanoparticles was determined by
absorbance at 280 nm using a Nanodrop 2000 spectro-
photometer. The hydrodynamic particle size distribution of
SMALPs was measured by dynamic light scattering (DLS)
using a Zetasizer Nano ZS. Samples (1 ml) were placed in a
semi-micro PS disposable polystyrene cuvette (Fischer Sci-
entiﬁc) and equilibrated at 25 °C for 5 min to ensure tem-
perature homogeneity prior to taking 16 measurements for
each sample, repeated three times. Data was analyzed using
Zetasizer software (V. 6.20). SMALPs were further char-
acterized with respect to their capacity to induce forward light
scatter (FSC; reﬂecting predominantly size, but also refractive
index and shape) and side scatter (SSC; indicative of geo-
metry and internal structure, or ‘granularity’) using ﬂow
cytometry in tandem with ﬂuorescein isothiocyanate (FITC)-
coupled second antibodies and excitation at 488 nm, adapted
for the analysis of nanoparticles by van der Vlist et al [11].
SMALPs (500 μl aliquots) in buffer pH 7.6 were labeled with
60 μM Nile Red (Invitrogen) for 30 min in the dark and
detected using a Miltenyi MACSQuant Analyzer with voltage
set between 300 V and 500 V, gated for ﬂuorescence (trigger
3.0) and subsequently back gated for SSC and FSC. Twenty
thousand events were collected for each sample and data
analyzed with Miltenyi MACS Quantify Software. Fluores-
cence was used as the parameter for setting the acquisition
trigger and the trigger level was adjusted to minimize
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electronic noise. All assays were performed three times on
separate days.
To determine if PBP2 and PBP2a were present in close
proximity within nanoparticles and membrane preparations,
proteins were cross-linked with 3,3′Dithiobis (sulfosuccini-
midylpropionate) (DTSSP) linked by a spacer arm of 12Ǻ
(Thermo Scientiﬁc). DTTSP was dissolved to a ﬁnal con-
centration of 10 mM in 300 μl of SMALP solution (25
mgml−1 protein) and incubated at 4 °C for 30 min. The cross-
linking reaction was quenched by the addition of 2.5 μl of
1M Tris-HCl, pH 7.5 and incubated for 15 min [12]. Cross-
links were cleaved by addition of 5% 2-mercaptoethanol
(Sigma) in tricine sample buffer. For immunoafﬁnity chro-
matography (IAC), protein G HP spintrap columns (GE
Healthcare Life Sciences) were equilibrated in Tris-buffered
saline (TBS; 50 mM Tris-HCl, 150 mM NaCl; pH 7.5),
antibody bound to the column (0.5–1.0 mgml−1 in 200 μl
TBS) and excess removed by washing. SMALPs (maximum
volume 500 μl) were added to the column, maintained with
shaking at 4 °C for 60 min, washed extensively with TBS and
centrifuged at 150 g for 1 min at 4 °C. Bound material was
eluted from the column with 100 μl 0.1 M glycine pH 2.5 and
centrifuged for 1 min at 1000 g; pH was neutralized with 1M
Tris-HCl pH 8.0. For co-immunoprecipitation (Co-IP), para-
magnetic beads coated with protein G (Dynal) and complexed
with either anti-PBP2 or anti-PBP2a antibodies were used to
purify PBP2/PBP2a-containing nanoparticles; SMALPs
(200–400 μl protein) were mixed with the Dynabeads and the
mixture incubated at 4 °C for 2 h with constant agitation. The
complex was eluted following manufacturer’s instructions
and captured proteins analyzed by SDS-PAGE and Western
blotting.
3. Results and discussion
Initially, attempts were made to solubilize PBP2/PBP2a
complexes from EMRSA-16 membranes with Triton X-100.
Cells from 1 l cultures were suspended in 1–4 ml of ice-cold
distilled water and disrupted using a FastPrep FP120
Homogenizer (Thermo Scientiﬁc). Cell wall debris was
removed by centrifugation (5000 g; 10 min; 4 °C), CMs col-
lected (130 000 g; 1 h; 4 °C) and the pellet suspended in
∼200 μl of 10 mM Tris-HCl (pH 7.0) containing 2% Triton
X-100 [8]. Exposure of solubilized proteins to DTSSP fol-
lowed by Co-IP with anti-PBP2 antibody failed to elicit cross-
linked PBP2/PBP2a; only PBP2 could be detected in Western
blots of Co-IP eluents separated by SDS-PAGE (ﬁgure S1; in
the supplementary ﬁle, available at stacks.iop.org/NANO/25/
285101/mmedia). We also attempted unsuccessfully (data not
shown) to cross-link the two proteins after solubilization with
1% formaldehyde (95 °C; 5 min). We conclude that any
PBP2/PBP2a complexes are disrupted by detergent extrac-
tion; this accords with published reports demonstrating
recovery of PBPs by non-ionic detergents in exclusively
monomeric form [13, 14]. Consequently, we examined the
potential of SMA co-polymer solubilization to reveal the
presence of closely associated PBP2/PBP2a.
As the composition of the staphylococcal CM is unusual,
we determined if SMA was able to solubilize proteins from
puriﬁed EMRSA-16 membranes. Cells were suspended in
3 ml 20% sucrose, 0.05 M Tris-HCl, 0.145M NaCl (pH 7.6)
and the cell wall digested with 80 μg lysostaphin (with 25 μg
DNase I and protease inhibitors) for 10 min at 37 °C. SMA
was added to ﬁnal concentration of 2.5% and the mixture
(6 ml) incubated for 1 h at 37 °C; membranes were collected
by centrifugation (100 000 g; 1 h; 4 °C). Proteins were sepa-
rated by tricine-SDS-PAGE. Western blotting revealed the
presence of both PBP2 and PBP2a in SMALPs. As the pre-
paration of bacterial membranes may lead to redistribution of
bilayer protein and lipid, we modiﬁed this procedure to enable
solubilization of PBPs from intact cells; the lysostaphin
digestion components were added to 3 ml bacterial suspen-
sion from 2 l culture and incubated for 10 min at 37 °C prior
to addition of SMA. Omission of this cell wall digestion step
resulted in failure to extract membrane proteins; lysostaphin,
which disrupts the pentaglycine cross-bridges of peptidogly-
can [15], breached the integrity of the cell wall as determined
by TEM (ﬁgure 1(B)). After addition of SMA and further
50 min incubation, SMALPs were recovered from the
supernatant (100 000 g; 1 h; 4 °C). TEM showed that partial
digestion of the cell wall was necessary to allow ingress of
SMA and egress of SMALPs (ﬁgure 1(C)). Initial experi-
ments included sonication of bacteria and 16 h incubation at
37 °C prior to centrifugation, as these steps were considered
essential to obtain homogeneous preparations of SMA lipo-
somal extracts [2, 3], but neither were found to be necessary
for membrane protein extraction and were omitted from our
optimized protocol, as sonication is likely to disrupt physical
associations between membrane proteins. The amount of
membrane protein extracted from EMRSA-16 by SMA was
comparable to that extracted by 2% Triton X-100 (ﬁgure S2).
TEM images of material solubilized by SMA from
DMPC vesicles, S. aureus SH1000 and EMRSA-16 revealed
monodispersed, homogeneous suspensions (ﬁgure 2) with
mean diameters of 12 ± 2 nm (±1SD) for particles from pro-
tein-free DMPC vesicles and 18 ± 3 nm and 24 ± 5 nm (all
n = 75) for those from SH1000 and EMRSA-16, indicating
that incorporation of proteins results in SMALPs of increased
size. Nanoparticle size distribution and dispersion were
investigated by DLS and ﬂow cytometry (ﬁgure 3). DLS
conﬁrmed the monodispersed nature of SH1000 and
EMRSA-16 preparations and indicated that hydrodynamic
diameters of SMALPs were 17.4 ± 2.23 nm and
24.5 ± 2.64 nm, in good agreement with measurements from
TEM. Although these nanoparticles are close to the lower
limits of detection, they were readily quantiﬁed and analyzed
by ﬂow cytometry, employing ﬂuorescence threshold trig-
gering to discriminate ﬂuorescently labelled SMALPs from
non-ﬂuorescent noise [11]. Figure 3(A) shows the forward-
(inﬂuenced by size, refractive index, shape) and side-scatter
distribution (geometry, internal structure) of nanoparticles
from EMRSA-16, visualizing both Nile Red-labeled
SMALPs and noise events. SMALPs labeled with the lipo-
philic dye Nile Red could be discriminated from non-ﬂuor-
escent noise (ﬁgure 3(B)); raising the ﬂuorescence threshold
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to eliminate noise (ﬁgure 3(C)) showed that the majority of
particles formed a homogeneous population with respect to
forward- and side-scatter but with a short tail of small ﬂuor-
escent particles (ﬁgures 3(C) and (D)). When particles were
stained with Nile Red (for lipid) and Bocillin FL (for PBPs)
and examined by ﬂuorescence microscopy, the two stains co-
localized, indicating successful protein extraction. PBP2 and
PBP2a were detected in unfractionated SMALPs from
EMRSA-16 by Western blotting.
Protein-containing SMALPs were enriched by IAC or
Co-IP; prior to enrichment, proteins separated by 12Ǻ or less
were cross-linked with DTSSP. IAC was employed to
determine if PBP2 or PBP2a could be detected in protein
complexes recovered using antibodies raised against FtsZ.
Western blotting of proteins from EMRSA-16 SMALPs
reacting with anti-FtsZ antibodies contained PBP2, PBP2a
and FtsZ (ﬁgure 4), indicating that these proteins exist on or
within the CM in close spatial proximity. IAC and Co-IP with
both anti-PBP2 and anti-PBP2a antibodies yielded nano-
particles in which PBP2 and PBP2a, but not FtsZ, could be
detected in Western blots with the appropriate antibodies, but
the bands were less prominent in comparison to blots of anti-
FtsZ-recovered nanoparticles, almost certainly reﬂecting the
low number of copies of PBPs in each S. aureus cell [16].
ECg completely abolishes β-lactam resistance in clinical
MRSA isolates; it reduces the minimum inhibitory con-
centration of oxacillin required to prevent growth of EMRSA-
16 from 512 to <1 mg l−1, due to its capacity to intercalate
deep within the CM, fundamentally altering the biophysical
characteristics of the bilayer and forcing the bacteria to
respond by reconﬁguration of CM architecture [8, 17]. The
polyphenol induces partial delocalization of PBP2 from the
septal divisome [8], indicating that reversible sensitization to
β-lactam antibiotics may be due to dissipation of the PBP2/
PBP2a-facilitiated resistance machinery. In this study, it is
clear that 12.5 mg l−1 ECg alters the spatial relationship
between these two proteins, as PBP2a can no longer be
recovered by SMA extraction and capture with anti-FtsZ
antibodies (ﬁgure 4), providing support for this supposition.
Eluents from Co-IP were also investigated by analytical
ﬂow cytometry. SMALPs were enriched with anti-PBP2
antibodies, lipid labeled with Nile Red and probed with anti-
PBP2a antiserum and FITC-conjugated second antibody.
Conversely, nanoparticles enriched with anti-PBP2a were
probed for the presence of PBP2. In both cases, the partner
protein was readily detected, with 8260 of 20 000 reacting
with anti-PBP2a antibodies after enrichment with anti-PBP2
antibodies and 7260 of 20 000 with anti-PBP2 antibodies after
enrichment with anti-PBP2a antibodies (ﬁgure 5). These data
provide strong evidence that PBP2 and PBP2a are in close
spatial proximity following recruitment by FtsZ and are
recovered from the CM in ∼40% of SMALPs. It is likely that
this reﬂects the proportion of PBP2/PBP2a complexes
actively involved in cell division, with the remainder
Nanotechnology 25 (2014) 285101 S Paulin et al
4
Figure 1. TEM of (A) EMRSA-16 cell, (B) after 10 min exposure to lysostaphin (26.7 mg l−1), (C) after 10 min lysostaphin digestion
followed by 2.5% SMA and incubation for 50 min. Two SMALPs of diameter 37.9 nm and 32.8 nm can be seen. Scale bar = 100 nm.
Figure 2. TEM of (A) DMPC, (B) SH1000 membranes and (C) EMRSA-16 membranes incorporated into SMALPs. Bacterial membranes
were solubilized directly from viable bacteria with no intermediate membrane puriﬁcation step. Scale bar = 100 nm.
recovered from regions of the membrane other than those
accommodating divisome complexes. Flow cytometry pro-
vided further evidence that exposure of EMRSA-16 to 12.5
mg l−1 ECg caused partial dissociation of PBP2/PBP2a
complexes. Co-IP of SMALPs from control and ECg-exposed
cells was undertaken with anti-PBP2 and anti-PBP2a anti-
bodies and PBP2 and PBP2a quantiﬁed with the appropriate
antibody combinations. With anti-PBP2 Co-IP pull down,
there was a 1.76-fold reduction in the PBP2/PBP2a ratio
following ECg exposure, reﬂecting a reduction in PBP2a
FITC ﬂuorescence (normalized against PBP2 Nile Red
ﬂuorescence) from 231.6 arbitrary ﬂuorescence units (AFU)
to 131.6 AFU. With anti-PBP2a Co-IP, a 1.43-fold reduction
was observed, corresponding to a reduction in normalized
PBP2a ﬂuorescence from 53.7 AFU to 37.6 AFU. Flow
cytometry scatter plots from these experiments are shown in
ﬁgure S3. Flow cytometry was used as it is a highly sensitive,
quantitative method with a much lower limit of detection
compared to semi-quantitative Western blotting. In this con-
text, we were unable to detect a band corresponding to PBP2a
by Western blotting of SMA-extracted proteins from ECg-
exposed EMRSA-16 cells; ﬂow cytometry clearly indicated
residual PBP2a, in agreement with a study showing partial,
rather than complete, disruption of the complex [8]. Also of
note was our ability to obtain ﬂuorescence data by ﬂow
cytometry from nanoparticles of 20–25 nm diameter, using
methods [11] designed for detection and analysis of vesicles
of ∼100 nm.
We show for the ﬁrst time that SMA trapping of mem-
brane domains can be used to extract native membrane-
embedded protein complexes directly from intact bacteria.
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Figure 3. Size determination of SMALPs from EMRSA-16 membranes. Upper panel: distribution of hydrodynamic radii determined by DLS.
Lower panel: ﬂow cytometry of SMALPs labeled with 60 μM Nile Red by (A) size (forward scatter; FSC-A) and granularity (side scatter;
SSC-A), no discrimination between ﬂuorescent and non-ﬂuorescent nanoparticles, all arbitrary units; (B) ﬂuorescence intensity of Nile Red
within SMALPs (red) and non-ﬂuorescent SMALPs (black); (C) separation of SMALPs labeled with Nile Red by ﬂuorescence sorting;
number of particles in the scatter plot follow the transition from blue (low) through green to red (high); (D) size distribution (FSC-A) of Nile
Red-labeled SMALPs.
Figure 4. Western blots of EMRSA-16 SMALP proteins recovered
by anti-FtsZ IAC. Bacteria were grown in the absence (−ECg) or
presence (+ECg) of the drug resistance modiﬁer ECg (12.5 mg l−1)
and proteins probed with anti-PBP2 (A), anti-PBP2a (B) and anti-
FtsZ (C) antibodies. Arrows indicate the target protein in each blot.
Other studies [2–4] have effected removal of single proteins
within model lipid bilayers or over-expressed proteins from
protoplasts of viable bacteria. The latter approach would not
be suitable for SMALP enrichment of divisome proteins as
key components remain at the septum due to interactions with
D-alanyl-D-alanine termini on nascent peptidoglycan chains
[18]; removal of the cell wall will destroy this anchor and
delocalize proteins. It was necessary to minimally digest the
cell wall whilst retaining overall architecture and we estab-
lished that 10 min lysostaphin digestion of whole cells led to
optimal cell wall perturbation compatible with protein
extraction. SMA solubilized substantial amounts of protein
from the membrane but native PBP2 and PBP2a copy num-
bers are low and this restricted our capacity to purify enough
protein using PBP-speciﬁc antisera for analysis by Western
blotting, but not by the more sensitive ﬂow cytometry tech-
nique. In contrast, there are many more copies of FtsZ, the
major cytoskeletal protein, within the membrane bilayer [19].
The presence of FtsZ within PBP2/PBP2a-containing nano-
particles could only be demonstrated when anti-FtsZ
Nanotechnology 25 (2014) 285101 S Paulin et al
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Figure 5. Flow cytometry of EMRSA-16 SMALPs enriched for PBP2 and PBP2a by Co-IP. Nanoparticles were labeled with Nile Red and
size (forward scatter; FSC-A) and granularity (side scatter; SSC-A) determined after pull down with (A), (B) anti-PBP2 and (C), (D) anti-
PBP2a antibodies. Nanoparticles from A were labeled with murine anti-PBP2a antibodies followed by FITC-conjugated anti-mouse IgG
secondary antibody (B) and those from B with rabbit anti-PBP2 antibodies and FITC-conjugated anti-rabbit IgG second antibody (D). In each
experiment, 20 000 Nile Red-labeled nanoparticles; 8260 reacted with anti-PBP2a antibodies when enriched with anti-PBP2 antibodies (B)
and 7260 with anti-PBP2 antibodies when enriched with anti-PBP2 antibodies (D).
antiserum was used for puriﬁcation by IAC. SMALP capture
of FtsZ, PBP2 and PBP2a with antiFtsZ antiserum shows that
the procedure can remove large protein complexes. The S.
aureus division machinery is comprised of many membrane-
located and cytosolic proteins that interact with the FtsZ
scaffold: removal of functionally active components of the
divisome in a spatially relevant manner will provide a new
tool for elucidation of their complex interactions.
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